COMMUNIQUÉS West-GlobeNewswire
-
Is Walking Your Dog Enough?
26/08/2026 -
Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
26/08/2026 -
NeOnc’s Clinical Story Is Now the Main Event
26/08/2026 -
Addressing Mental Health Disparities for Minorities
26/08/2026 -
Cruel Summer: How Heat Can Turn Substance Use into a Medical Emergency
26/08/2026 -
Spinal Rehab & Sports Medicine Kicks Off Back-to-School Sports Season Celebrating Nearly 30 Years of Elite-Level Care in Austin TX
26/08/2026 -
Scene Health Appoints Lisa Ritsky-Lamb as Chief Financial Officer to Accelerate Next Phase of Growth
26/08/2026 -
JAMA Dermatology Publishes Skin-Specific Outcomes from Phase 3 VALOR Trial Of Brepocitinib in Dermatomyositis
26/08/2026 -
RAMSAY SANTE : Résultats annuels provisoires à fin juin 2026
26/08/2026 -
RAMSAY SANTE : Provisional annual results at the end of June 2026
26/08/2026 -
INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings
26/08/2026 -
Ligand to Participate in September Investor Conferences
26/08/2026 -
Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors
26/08/2026 -
Wellness Together and TadHealth Partner to Expand Student Behavioral Health Support Through CYBHI
26/08/2026 -
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
26/08/2026 -
Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
26/08/2026 -
MicrobiotiX Completes Sentinel Cohort of its First-in-human Clinical Trial of MP101 for Pneumonia
26/08/2026 -
Eikon Therapeutics to Participate in Investor Conferences in September 2026
26/08/2026 -
BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM
26/08/2026
Pages